ISLAMABAD: The Higher Education Commission (HEC) on Friday said it has initiated a project to revamp its degree attestation system by integrating cutting-edge blockchain technology. “This pivotal ...

China has suspended export controls announced this month, but was conspicuously silent about rules imposed earlier, which are snarling global supply chains. By Keith Bradsher Reporting from Beijing ...

SHENZHEN, CHINA - APRIL 12: A Chinese national flag is seen in the foreground with container ships, cranes, and stacked shipping containers at the Yantian International Container Terminal under cloudy ...

China tightened export controls for critical rare-earth metals on Thursday. The new restrictions, announced by the Ministry of Commerce, come in advance of an expected meeting between United States ...

The RPSC has announced the RAS mains result 2025, with 2,461 candidates declared successful. The mains exam was held on June 17 and 18, 2025, across multiple centres in Rajasthan in two shifts daily.

Copenhagen, Sep. 24 (BNA): Export Bahrain announced that Estedara, a pioneering startup from Bahrain, has been recognised as the "Top Strategic Startup" at the 2025 Creative Business Cup (CBC) Final ...

Measure meant to build up needed foreign reserves Suspension to last through end-October or $7 billion cap reached Exporters groups warn of supply glut Markets rally on tax cut, U.S. support pledge ...

Most users don’t clear their browser history as they will always want to find or revisit webpages long forgotten in the chaos of the World Wide Web. For multiple PC users, even with the many ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

Section 1. Purpose. Artificial intelligence (AI) is a foundational technology that will define the future of economic growth, national security, and global competitiveness for decades to come. The ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.